Brief: Oncoarendi Therapeutics 9-Month Net Loss Widens To 2.6 Mln Zlotys
29/11/2018 16:37
Nov 29 (Reuters) - Oncoarendi Therapeutics SA OAT.WA :
* 9-MONTH NET LOSS OF 2.6 MILLION ZLOTYS VERSUS LOSS OF 0.8 MILLION ZLOTYS
YEAR
AGO
Source text for Eikon: ID:nEM60gbmJa
Further company coverage: OAT.WA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments